Spatial transcriptomics characterisation of radionecrotic changes in glioblastoma patients.
Saved in:
| Title: | Spatial transcriptomics characterisation of radionecrotic changes in glioblastoma patients. |
|---|---|
| Authors: | Seferbekova Z; Division of AI in Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Ritter M; Division of AI in Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Rukhovich G; Division of AI in Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Schinkewitsch S; Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg University, Heidelberg, Germany., Köberer N; Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Grassl N; Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Neurology, Medical Faculty Mannheim (UMM), The Mannheim Center for Translational Neuroscience (MCTN), Heidelberg University, Mannheim, Germany.; DKFZ-Hector Cancer Institute at University Medical Center Mannheim, Mannheim, Germany., Deng MY; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany (M.Y.D., J.D.)., Ruder AM; Department of Radiation Oncology, University Medical Centre Mannheim, Mannheim, Germany., König L; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany., Debus J; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany (M.Y.D., J.D.)., Hanning U; Department of Neuroradiology, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany., Giordano FA; DKFZ-Hector Cancer Institute at University Medical Center Mannheim, Mannheim, Germany.; Department of Radiation Oncology, University Medical Centre Mannheim, Mannheim, Germany.; Mannheim Institute for Intelligent Systems in Medicine (MIISM), Medical Faculty, Heidelberg University, Mannheim, Germany., Kessler T; Department of Neurology and Neurooncology Program, National Center for Tumor Diseases (NCT) and European Center for Neurooncology (EZN), Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Neurooncology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Goidts V; Brain Tumor Translational Targets, German Cancer Research Center (DKFZ), Heidelberg, Germany., Ratliff M; Department of Neurosurgery, University Hospital Mannheim, Medical Faculty Mannheim (UMM), University of Heidelberg, Mannheim, Germany.; Clinical Cooperation Unit Neurooncology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Herold-Mende C; Division of Experimental Neurosurgery, Department of Neurosurgery, Heidelberg University, Heidelberg, Germany., Krieg SM; Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany., Etminan N; Department of Neurosurgery, University Hospital Mannheim, Medical Faculty Mannheim (UMM), University of Heidelberg, Mannheim, Germany., Platten M; Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Neurology, Medical Faculty Mannheim (UMM), The Mannheim Center for Translational Neuroscience (MCTN), Heidelberg University, Mannheim, Germany.; DKFZ-Hector Cancer Institute at University Medical Center Mannheim, Mannheim, Germany.; Immune Monitoring Unit, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Helmholtz Institute for Translational Oncology (HI-TRON) Mainz, German Cancer Research Center (DKFZ), Mainz, Germany., Wick W; Department of Neurology and Neurooncology Program, National Center for Tumor Diseases (NCT) and European Center for Neurooncology (EZN), Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Neurooncology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Reuss D; Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., von Deimling A; Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Sahm F; Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Gerstung M; Division of AI in Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; University Hospital Tübingen, Tübingen, Germany., Suwala AK; Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. |
| Source: | Neuro-oncology [Neuro Oncol] 2026 May 01; Vol. 28 (5), pp. 1150-1162. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
